# FDA Inspection 1233323 - Zhejiang Excel Pharmaceutical Company, Ltd. - April 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-excel-pharmaceutical-company-ltd/a870df77-720e-41a2-b2f7-0c5cc129b484
Source feed: FDA_Inspections

> FDA Inspection 1233323 for Zhejiang Excel Pharmaceutical Company, Ltd. on April 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233323
- Company Name: Zhejiang Excel Pharmaceutical Company, Ltd.
- Inspection Date: 2024-04-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 963958 - 2016-04-01](https://www.keypedia.com/records/fda_inspections/zhejiang-excel-pharmaceutical-company-ltd/980c711e-bd98-426a-b09d-e946375b92e2)
- [FDA Inspection 819131 - 2013-01-31](https://www.keypedia.com/records/fda_inspections/zhejiang-excel-pharmaceutical-company-ltd/6d1b79ab-730d-430a-b609-004fd5678fe8)
- [FDA Inspection 565822 - 2009-01-28](https://www.keypedia.com/records/fda_inspections/zhejiang-excel-pharmaceutical-company-ltd/531b2572-aabd-4345-85ce-c74d749f80b5)

Company: https://www.keypedia.com/companies/zhejiang-excel-pharmaceutical-company-ltd/4895da03-f853-4a18-b30d-9b4a3dbc3189

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c